The Science of Medical Cannabis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cannabis – a Complex and Rapidly Evolving Landscape
CANNABIS – A COMPLEX AND RAPIDLY EVOLVING LANDSCAPE Abstract ABOUT THE AUTHOR The humble Cannabis sativa plant, cultivated for millennia for its psychoactive properties and more, is today considered one of the most controversial and complex plants in the world. Starting in the early to mid-20th century, much of its use became recreational, but by the early 1970s discoveries began to emerge around its potential medical efficacies. This article will discuss current knowledge of how cannabis engages with the brain and the endocannabinoid system (ECS) and provide an overview of the new market landscapes brought about by changes in governing laws Dr. Georgiana Willwerth-Pascutiu and regulations, which are affecting usage by our current and potential [email protected] customers. It will also explore the additional hazards, concerns, and Georgiana Willwerth-Pascutiu is Vice President, Global Medical Director considerations of cannabis use in countries where it remains illegal. at RGA. She is board certified in Insurance Medicine by the American Introduction Academy of Insurance Medicine (AAIM) and specialized in internal medicine, Naturally occurring psychoactive substances have been part of human life nephrology and ultrasonography. for millennia. One of the most frequently utilized plant sources of these Dr. Willwerth-Pascutiu is also a past substances, Cannabis sativa, is also the best-known worldwide. For the president of the Canadian Life Insurance Medical Officers Association (CLIMOA) past half-century, scientific and medical interest in its many compounds, and currently chairs its scientific known as cannabinoids, has been increasing. Today, the two best-known, committee. She is a frequent presenter and has contributed several articles to delta-9 tetrahydrocannabinol (THC), its psychoactive chemical, and insurance industry publications. -
A Review on Cannabis Sativa: Its Compounds and Their Effects
Int. J. Pharm. Sci. Rev. Res., 53(2), November - December 2018; Article No. 12, Pages: 59-63 ISSN 0976 – 044X Review Article A Review on Cannabis sativa: Its Compounds and Their Effects Ranju Rajput, *Dr. Krishan Kumar Department of Food and Biotechnology, Jayoti Vidyapeeth Women’s University, Jaipur, Rajasthan, India. *Corresponding author’s E-mail: [email protected] Received: 01-11-2018; Revised: 25-11-2018; Accepted: 10-12-2018. ABSTRACT Our society often considered the use of cannabis is an under-reported activity. Cannabis is used to relieve neuropathic and chronic pain. Cannabis, produced from the Cannabis sativa plant, have been used in three forms: herbal cannabis, the dried leaves and flowering tops The resin of the cannabis is the pressed secretions of the plant, known as ‘hashish’ or ‘charash. Cannabis sativa is an herbaceous species originated from Central Asia. It has been used in medicine and as a source of textile fiber since ancient times. The cannabis sativa is a fast growing plant attracted the people’s interest because of its multi-purpose applications. It is a rich source of photochemical, cellulose and woody fibers. The more interest is also due to its metabolites which show potent bioactivities on human health. In this review, the phytochemicals is discussed by putting a special emphasis on molecules including cannabinoids, terpenes and phenolic compounds. Cannabinoids are represented as the most studied group of compounds, because of their wide range of pharmaceutical effects in humans, including psychotropic activities. This article aims to update the current knowledge and evidence of using cannabis and its derivatives with a view to the sociolegal context and perspectives for future research. -
Extracts and Tinctures of Cannabis
WHO Expert Committee on Drug Dependence Critical Review …………….. Extracts and tinctures of cannabis This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization © World Health Organization 2018 All rights reserved. This is an advance copy distributed to the participants of the 41st Expert Committee on Drug Dependence, before it has been formally published by the World Health Organization. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. -
Dispensary Selection Information
______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones. -
Big-Catalogue-English-2020.Pdf
PAS CH SIO UT N D ® CATALOGUE English SEED COMPANY Feminized, autoflower and regular cannabis seeds AMSTERDAM, ESTABLISHED 1987 for recreational and medical use. Amsterdam - Maastricht YOUR PASSION OUR PASSION DUTCH PASSION 02 Contents Welcome to Dutch Passion Welcome to Dutch Passion 02 Dutch Passion was the second Cannabis Seed Company in the world, established in Amsterdam in 1987. It is our mission to supply Bestsellers 2019 02 the recreational and medical home grower with the highest quality cannabis products available in all countries where this is legally Regular, Feminized and Autoflower 03 allowed. Cannabinoids 03 Medical use of cannabis 03 After many years of dedication Dutch Passion remains a leading supplier of the world’s best cannabis genetics. Our experienced Super Sativa Seed Club 04 team do their utmost to maintain the quality of our existing varieties and constantly search for new ones from an extensive network Special Cannabinoids / THC-Victory 05 of worldwide sources. We supply thousands of retailers and seed distributors around the world. Dutch Outdoor 06 High Altitude 09 CBD Rich 10 Dutch Passion have never been afraid to upset conventional thinking; we invented feminized seeds in the 1990’s and more recently Latin America 13 have pioneered the introduction of 10-week Autoflower seeds which have helped make life even easier for the self-sufficient Classics 14 cannabis grower. CBD-rich medical cannabis genetics is a new area that we are proud to be leading. Skunk Family 19 Orange Family 21 The foundation of our success is the genetic control we have over our strains and the constant influx of new genetics that we obtain Blue Family 24 worldwide. -
Cannabis Terminology 101
Super Animal Care Solutions TECHNICAL BULLETIN Cannabis Terminology 101 Cannabis or Hemp? nabinol). Contrary to what many pot smok- Cannabidiol-CBD Cannabis refers to a broad category of ers may tell you, marijuana is addictive. A naturally occurring constituent/cannabi- plants, including both hemp and marijuana. Even among occasional users, one in 12 can noid of the hemp plant. It is the most abun- Hemp is a specific type of cannabis plant feel withdrawal symptoms if they can’t get dant, non-psychoactive cannabinoid in that contains less than 0.3% THC. high when they want to. Many experts also hemp/cannabis, and reacts primarily with believe marijuana is physically addictive. CB-2 receptors that are generally concen- Cannabis trated in peripheral organs and cells asso- The name given to the plant itself. A total of Medical Cannabis/Medical Marijuana ciated with the immune system. 480 natural components have been found Cannabis used as a physician-recom- within the cannabis plant. There are three mended form of medicine or herbal thera- The Vediol blend delivers a highly purified major types of cannabis (plus multiple hy- py typically higher in THC content – (higher cannabinoid consortium, devoid of THC, brids), distinguished by very different char- than 0.3%) than other species of cannabis. designed for maximum effectiveness. While acteristics and traits they display: no causal link has been established, abun- Tetrahydrocannabinol-THC dant research would suggest non-human • Cannabis sativa delta-9-tetrahydrocannabinol. This is a con- patients may benefit from receiving hemp • Cannabis indica trolled substance. The only thus far identi- derived CBD in support of their endocan- • Cannabis ruderalis fied psychoactive component of cannabis nabinoid system. -
About the Endocannabinoid System (ECS)
Mana Artisan Botanics Frequently Asked Questions | 1 Frequently Asked Questions About the Endocannabinoid system (ECS) What is the Endocannabinoid What are Endocannabinoids? System, or ECS? Endocannabinoids are endogenous neurotransmitters that Discovered in the late 1980s, the Endocannabinoid System, or are produced by our bodies. They regulate neurotransmission ECS is a biological system found in all mammals, composed and allow for feedback loops. Anandamide and 2-Arachido- of endocannabinoids and cannabinoid receptors. ECS affects noylglycerol (2-AG) are the two primary endocannabinoids. virtually every cell, muscle, organ and tissue in our body, and critical to regulating a wide range of body processes, our What are Phytocannabinoids and nervous system, immune system, digestive system, endocrine how are they different than glands, brain, heart, lungs, kidneys, liver, spleen, bones, mus- Endocannabinoids? cles, blood vessels and cells, lymph cells, and fat cells. Phytocannabinoids are plant derivative compounds (primarily The ECS is believed to have more cellular receptor sites than extracted from cannabis) that mimic the characteristics of the any other receptor system. The widespread distribution of endocannabinoids. THC and Cannabidiol (CBD) are the two these cannabinoid receptors shows just how important the primary phytocannabinoids that mimic the endocannabinoids ECS is to our overall bodily function and health. Anandamide and 2-AG, respectively. Both endocannabinoid and phytocannabinoids, collectively referred to as cannabinoids, -
The Entourage Effect of Whole-Plant Medicine
CANN BIS THE ENTOURAGE EFFECT OF Whole-Plant, WHOLE-PLANT MEDICINE Whole Medicine BY DEBORAH PARKER WONG ithin the last decade, scientists have dis- as well as the less-known such as CBDV, a proven covered hundreds of biologically active anti-epileptic. W nutrients called phytochemicals, which are Food and health researchers have long concluded found in whole, unprocessed foods. There’s pteros- that while our bodies readily absorb these kinds of tilbene, a powerful antioxidant found in almonds, nutrients from whole foods, our ability to absorb syn- blueberries and Pinot Noir grapes that enables cells thetic, isolated supplements is limited at best. That’s exactly what cannabis researchers at the Hebrew University of Jerusalem discovered when comparing the efficacy of whole-plant cannabinoid (CBD) ex- tracts with synthetic, single-molecule CBDs. As the pharmaceutical industry rushes to market synthetic CBDs, research points to what’s called the “Entourage Effect,” wherein compounds work- ing together synergistically in whole-plant medi- cines amplify the overall effects and benefits of the medicine. When comparing synthetic CBDs with whole-plant extract, the Israeli researchers ob- served a narrow therapeutic window that limits the to break down fat and cholesterol; compounds like usefulness of the synthetic form and a far greater lycopene, which colors tomatoes red, and antho- range of effectiveness for CBD-rich, whole-plant cycanin, which gives berries of all kinds their deep extract. This, combined with the Entourage Effect, hues of blue. And of course, there’s the exciting makes whole-plant CBD extracts more effective at world of phytocannabinoids, cannabis-derived com- lower doses, with fewer adverse side effects, mak- pounds including the famously psychoactive THC, ing it ideal for clinical use. -
Seed Catalogue 2016
SEED CATALOGUE 2016 BREEDER OF CHAMPIONS Since 1986 CBD Critical Cure 4 CBD Blue Shark 4 Pineapple Express Auto 5 Cookies Kush Blue Mammoth Auto 5 Sweet Tooth Auto 6 Malana Bomb Auto 6 Triple Cheese Sin Tra Bajo Auto 7 Critical Kush Auto 7 Blue Cheese Auto 8 NYC Diesel Auto 8 Critical Kush Cookies Kush 9 Triple Cheese 9 Critical Kush 10 Pineapple Chunk 10 Liberty Haze Ayahuasca Purple 11 Bad Azz Kush 11 Tangerine Dream 12 Ayahuasca Liberty Haze 12 Purple Blue Cheese 13 LSD 13 G13 Haze 14 Bad Azz Kush Peppermint Kush 14 Vanilla Kush 15 Sweet Tooth 15 Laughing Buddha 16 G-13 Haze Utopia Haze 16 Amnesia Lemon 17 Dr. Grinspoon 17 Vanilla Kush Morning Glory 18 Chronic Thunder 18 Acapulco Gold 19 Red Diesel 19 Dr. Grinspoon Red Cherry Berry 20 Phatt Fruity 20 Red Dragon 21 8 Ball Kush 21 Morning Glory Violator Kush 22 Top Dawg 22 Honey B 23 www.barneysfarm.com Amnesia Lemon Crimea Blue 23 Pineapple CBD Critical Cure (Medical feminized) Express Auto 20% Sativa. 80% Indica 30% Sativa. 70% Indica 600 gr/m² 600 gr/m² 90/100 cm 100/110 cm 55/60 days 60/65 days End September from Germination 5.5% 8.0% 14% 1.2 - 1.4% € 28 € 22 € 42 € 32 € 76 € 58 Barneys Farm / CBD Crew – Critical Cure. Pineapple Chunk X Super Auto. The legendary Indica dominant Critical Kush crossed with Shanti Baba’s CBD Pineapple Express Auto is the autoflowering version of the original Pineapple Enhanced strain. The fast flowering CBD Critical Cure plant produces huge, Chunk. -
15/Gram - $50/3.5 Grams Select Flower - $13/Gram** STRAIN DESCRIPTIONS
30 Mozzone Boulevard, Taunton, MA 02780 http://commonwealthaltcare.org/ (508) 738-6380 Flower Menu - $15/gram - $50/3.5 Grams Select Flower - $13/gram** STRAIN DESCRIPTIONS Strain Lineage Type Available In TAC Effects and Aroma Mendo Purps x Sativa 1.0 G THCA 13.1 Hashy with savory undertones. Great body high, very happy and Triangle Kush #4 x Hybrid CBGA .4 Item 9** Stardawg Haze comforting Hybrid 1.0 G THCA 10.5 A hybrid strain, perfect for pain, relaxation, inflammation, and stress CBC .6 Echo** relief Gorilla Glue #4 x Sativa 1.0 G THCA 20.8 A sweet mandarin orange aroma with woody undertones. Great for Tangie Hybrid CBGA .8 Citrus Sap mood elevation, stress, inflammation, and pain relief Blue Dream x Hybrid 1.0 G THCA 21.4 Blueberry aroma with spice and sweet herbal notes. Effects are Snow Lotus CBGA .3 uplifting and promote relaxation and focus. Great for stress, pain, Dream Lotus inflammation, and spasticity White Widow x Hybrid 1.0 G THCA 17.2 A nutty, coffee aroma with earthy undertones. Heavily relaxing Skywalker CBGA .6 effects, boosting both mood and appetite. Great for stress relief and White Walker Kush treating anorexia and cachexia Moonshine Haze x Hybrid 1.0 G THCA 21.5 Spicy, sweet, and fruit aromas. A balanced hybrid that’s both Double Purple CBGA 1.1 Moonrise Doja energetic and relaxing Afghani x Thai x Indica 1.0 G THCA 23.2 Strong indica strain that emanates sweet blueberry aromas. Heavy Purple Thai CBGA .5 3.5 G relaxation effects, paired with a euphoric sensation. -
Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model
Glaucoma Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model Sally Miller,1 Emma Leishman,1 Sherry Shujung Hu,2 Alhasan Elghouche,1 Laura Daily,1 Natalia Murataeva,1 Heather Bradshaw,1 and Alex Straiker1 1Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States 2Department of Psychology, National Cheng Kung University, Tainan, Taiwan Correspondence: Alex Straiker, De- PURPOSE. Cannabinoids, such as D9-THC, act through an endogenous signaling system in the partment of Psychological and Brain vertebrate eye that reduces IOP via CB1 receptors. Endogenous cannabinoid (eCB) ligand, 2- Sciences, Indiana University, Bloom- arachidonoyl glycerol (2-AG), likewise activates CB1 and is metabolized by monoacylglycerol ington, IN 47405, USA; lipase (MAGL). We investigated ocular 2-AG and its regulation by MAGL and the therapeutic [email protected]. potential of harnessing eCBs to lower IOP. Submitted: February 16, 2016 Accepted: May 16, 2016 METHODS. We tested the effect of topical application of 2-AG and MAGL blockers in normotensive mice and examined changes in eCB-related lipid species in the eyes and spinal Citation: Miller S, Leishman E, Hu SS, cord of MAGL knockout (MAGLÀ/À) mice using high performance liquid chromatography/ et al. Harnessing the endocannabinoid tandem mass spectrometry (HPLC/MS/MS). We also examined the protein distribution of 2-arachidonoylglycerol to lower intra- ocular pressure in a murine model. MAGL in the mouse anterior chamber. Invest Ophthalmol Vis Sci. RESULTS. 2-Arachidonoyl glycerol reliably lowered IOP in a CB1- and concentration-dependent 2016;57:3287–3296. DOI:10.1167/ manner. Monoacylglycerol lipase is expressed prominently in nonpigmented ciliary iovs.16-19356 epithelium. -
Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back
International Journal of Molecular Sciences Review Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back Osnat Almogi-Hazan * and Reuven Or Laboratory of Immunotherapy and Bone Marrow Transplantation, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; [email protected] * Correspondence: [email protected] Received: 21 May 2020; Accepted: 19 June 2020; Published: 23 June 2020 Abstract: The Cannabis plant contains numerous components, including cannabinoids and other active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid system. Cannabinoids affect the nervous system and play significant roles in the regulation of the immune system. While Cannabis is not yet registered as a drug, the potential of cannabinoid-based medicines for the treatment of various conditions has led many countries to authorize their clinical use. However, the data from basic and medical research dedicated to medical Cannabis is currently limited. A variety of pathological conditions involve dysregulation of the immune system. For example, in cancer, immune surveillance and cancer immuno-editing result in immune tolerance. On the other hand, in autoimmune diseases increased immune activity causes tissue damage. Immuno-modulating therapies can regulate the immune system and therefore the immune-regulatory properties of cannabinoids, suggest their use in the therapy of immune related disorders. In this contemporary review, we discuss the roles of the endocannabinoid system in immunity and explore the emerging data about the effects of cannabinoids on the immune response in different pathologies. In addition, we discuss the complexities of using cannabinoid-based treatments in each of these conditions.